MCAM and breast carcinoma: First, the correlation between CD146 expression and the presence of CD44+/CD24low cells in breast cancer cell lines (data not shown) is consistent with previous observations at the mRNA level in cell lines [36], and supports the hypothesis that CD146 expression may be associated with the metastatic potential of breast tumor cells [37].